SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-020985
Filing Date
2022-06-03
Accepted
2022-06-03 16:40:37
Documents
2
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4126
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4672
  Complete submission text file 0000899243-22-020985.txt   10183
Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Issuer) CIK: 0001785530 (see all company filings)

IRS No.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address
Karunatilake Chulani (Reporting) CIK: 0001867326 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40366 | Film No.: 22995211